Table 4:

Univariate Cox model for progression-free survival and overall survival in patients with gliomas and glioblastomas

Variables	PFS			OS
	HR	95% CI	P Value	HR	95% CI	P Value
Gliomas (n = 51)
Age	1.036	1.009–1.063	.008	1.043	1.014–1.073	.004
Sexa	0.957	0.670–1.368	.811	0.896	0.606–1.325	.582
KPS	0.971	0.953–0.989	.002	0.970	0.952–0.988	.002
CBFmax	1.005	1.001–1.010	.027	1.003	0.998–1.008	.244
rCBFmax	1.670	1.149–2.427	.007	1.246	0.869–1.785	.232
GBM (n = 25)
Age	1.036	1.002–1.072	.039	1.030	0.994–1.067	.103
Sexa	0.851	0.547–1.323	.851	0.870	0.548–1.381	.555
KPS	0.986	0.963–1.008	.215	0.987	0.965–1.009	.242
CBFmax	0.997	0.989–1.005	.497	0.993	0.985–1.001	.070
rCBFmax	0.865	0.467–1.601	.644	0.563	0.306–1.035	.065

^aFemale versus male.